BackAlpha Healthcare Acquisition III - Warrants (01/04/2026) Overview
Alpha Healthcare Acquisition Corp III - Warrants (01/04/2026)

Alpha Healthcare Acquisition III - Warrants (01/04/2026) Return on Equity

Alpha Healthcare Acquisition III - Warrants (01/04/2026) (ALPAW) has a ROE of 78.49%, above the sector sector average of 11.67%.

Get informed when a big investor buys or sells

+ Follow

ROE

78.49%

Return on Equity

78.49%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Alpha Healthcare Acquisition III - Warrants (01/04/2026) (ALPAW) FAQ

Alpha Healthcare Acquisition III - Warrants (01/04/2026) (ALPAW) currently reports a ROE of 78.49%. That is above the sector sector average of 11.67%. Use the charts on this page to explore Alpha Healthcare Acquisition III - Warrants (01/04/2026)'s ROE history and peer comparisons.

Alpha Healthcare Acquisition III - Warrants (01/04/2026)'s ROE of 78.49% is higher than the its sector sector average of 11.67%. That is roughly 572.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Alpha Healthcare Acquisition III - Warrants (01/04/2026)'s current 78.49% should be judged against industry norms (sector average: 11.67%) and against ALPAW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 78.49%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.67%. From there, open related valuation or income-statement pages for Alpha Healthcare Acquisition III - Warrants (01/04/2026), and consider following ALPAW for alerts when major investors trade the stock.